HIGHLIGHTS
- who: Jinling Song from the The Investigational Review Board of Peking University Cancer Hospital approved the present study (IRB number: YJZ48)The requirement to acquire informed consent was waived owing to the Ethics Committee of Peking University Cancer Hospital. Retrospective data were collected with consecutive patients between January , and March , at Peking University Cancer Hospital based on the following criteria: (a) histologically proven CRC, (b) no prior treatment before , FDG PET/ CT scan, and (c) the presence of complete medical history and clinicopathological data. The exclusion criteria were (a) secondary malignant disease have published the research: Metabolic . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.